205 related articles for article (PubMed ID: 17434095)
21. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
[TBL] [Abstract][Full Text] [Related]
22. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
23. Clinical study on low-molecular weight heparin infusion as anticoagulation for nocturnal home haemodialysis.
Wong SS; Lau WY; Ng ML; Chan SY; Chan SF; Chan PK; Wan CK; Cheng YL
Nephrology (Carlton); 2018 Apr; 23(4):317-322. PubMed ID: 28052451
[TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparin in atherosclerotic stroke: a surprising resurrection of anticoagulants?
Bang OY; Kim JS
Stroke; 2012 Feb; 43(2):293-4. PubMed ID: 22076003
[No Abstract] [Full Text] [Related]
25. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
Charbonnier BA; Fiessinger JN; Banga JD; Wenzel E; d'Azemar P; Sagnard L
Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216
[TBL] [Abstract][Full Text] [Related]
26. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
28. Frequency of microemboli signal in stroke patients treated with low molecular weight heparin or aspirin.
Hao Q; Chang HM; Wong MC; Wong KS; Chen C
J Neuroimaging; 2010 Apr; 20(2):118-21. PubMed ID: 19141068
[TBL] [Abstract][Full Text] [Related]
29. Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results.
Strecker EP; Boos IB; Göttmann D; Vetter S
Eur Radiol; 2004 Feb; 14(2):302-8. PubMed ID: 12856136
[TBL] [Abstract][Full Text] [Related]
30. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
31. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
32. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Kay R; Wong KS; Yu YL; Chan YW; Tsoi TH; Ahuja AT; Chan FL; Fong KY; Law CB; Wong A
N Engl J Med; 1995 Dec; 333(24):1588-93. PubMed ID: 7477193
[TBL] [Abstract][Full Text] [Related]
33. Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
Engelter ST; Traenka C; Gensicke H; Schaedelin SA; Luft AR; Simonetti BG; Fischer U; Michel P; Sirimarco G; Kägi G; Vehoff J; Nedeltchev K; Kahles T; Kellert L; Rosenbaum S; von Rennenberg R; Sztajzel R; Leib SL; Jung S; Gralla J; Bruni N; Seiffge D; Feil K; Polymeris AA; Steiner L; Hamann J; Bonati LH; Brehm A; De Marchis GM; Peters N; Stippich C; Nolte CH; Christensen H; Wegener S; Psychogios MN; Arnold M; Lyrer P;
Lancet Neurol; 2021 May; 20(5):341-350. PubMed ID: 33765420
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Leong TS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD000119. PubMed ID: 28374884
[TBL] [Abstract][Full Text] [Related]
35. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
[TBL] [Abstract][Full Text] [Related]
36. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
Bath PM; Lindenstrom E; Boysen G; De Deyn P; Friis P; Leys D; Marttila R; Olsson J; O'Neill D; Orgogozo J; Ringelstein B; van der Sande J; Turpie AG
Lancet; 2001 Sep; 358(9283):702-10. PubMed ID: 11551576
[TBL] [Abstract][Full Text] [Related]
37. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
38. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
[TBL] [Abstract][Full Text] [Related]
39. Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin).
Mismetti P; Laporte-Simitsidis S; Navarro C; Sié P; d'Azemar P; Necciari J; Duret JP; Gaud C; Decousus H; Boneu B
Thromb Haemost; 1998 Jun; 79(6):1162-5. PubMed ID: 9657442
[TBL] [Abstract][Full Text] [Related]
40. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
Zinkstok SM; Roos YB;
Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
